Stjepanović Daniel, Kirkman Julia, Hall Wayne
National Centre for Youth Substance Use Research, School of Psychology, The University of Queensland, St Lucia, Australia.
Queensland Alliance for Environmental Health Sciences, The University of Queensland, Woolloongabba, Australia.
Addiction. 2025 Feb;120(2):380-384. doi: 10.1111/add.16693. Epub 2024 Oct 14.
Cannabinoid hyperemesis syndrome (CHS) is a (probably) rare syndrome that occurs in frequent and chronic cannabis users. It is characterised by cyclical vomiting and gastrointestinal symptoms. CHS is frequently misdiagnosed resulting in extensive investigations and delayed diagnosis and treatment. Standard anti-emetic treatments are typically not effective, and no standardised treatment protocol exists for CHS. Bathing or showering in hot water is often reported to relieve symptoms. Little is known of the aetiology of CHS as the literature is predominantly informed by case reports and chart reviews. Similarly, little is known of the demographics and cannabis use patterns of those who develop CHS. The number of CHS cases globally appears to have risen following liberalisation of cannabis regulation and access in some countries, underscoring the need for wider recognition of CHS in emergency care and by the wider public.
大麻素呕吐综合征(CHS)是一种(可能)罕见的综合征,发生于频繁且长期使用大麻的人群。其特征为周期性呕吐和胃肠道症状。CHS常被误诊,导致进行大量检查以及诊断和治疗延误。标准的止吐治疗通常无效,且尚无针对CHS的标准化治疗方案。经常有报告称,洗热水澡或淋浴可缓解症状。由于文献主要基于病例报告和图表回顾,对CHS的病因了解甚少。同样,对患CHS者的人口统计学特征和大麻使用模式也知之甚少。在一些国家大麻监管和获取放宽后,全球CHS病例数似乎有所上升,这凸显了在急诊护理以及更广泛的公众中更广泛认识CHS的必要性。